Metabolic
Retatrutide
20mg · ≥ 99%
GLP-1 / GIP / glucagon triple receptor research peptide
Retatrutide is a novel multi-agonist research peptide investigated for its concurrent activity at the GLP-1, GIP and glucagon receptors.
This 20mg vial is supplied in lyophilized form for advanced laboratory investigations into energy balance, glucose handling and metabolic signaling, where extended dosing models or higher-concentration reconstitutions are required.
Specifications
- Compound
- Retatrutide
- Strength
- 20mg per vial
- Form
- Lyophilised powder
- Purity
- ≥ 99%
- Storage
- Store at 2–8 °C
$129.00
Build your order & save
Save 5%
$122.55 per vial
Save 10%
$116.10 per vial
Save 15%
$109.65 per vial
Add 3 eligible vials to save 5%.
Mix & match any eligible individual vials — discount applied automatically at checkout. Kits are already discounted and are not included.
For research use only. Not for human consumption. Must be 18+ to purchase.
Have questions?
Reconstitution, dosing, storage, shipping — our researcher community and team answer daily on Telegram.
Join Telegram →Frequently bought together
Research-backed companion pairings. Each is grounded in peer-reviewed literature on complementary mechanisms — never duplicates of peptides already in this product.
Retatrutide
20mg · This item
MOTS-C
10mg · In stock
NAD+
1000mg · In stock
Tesamorelin
10mg · In stock
Bundle total (4 items)— 10% bulk discount applied
$365.40 $406.00
20mg
$129.00